A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...

In this Innovation Spotlight, Cameron Ferris, the co-founder and chief operating officer of Inventia Life Science, discusses why and how 3D cell culture is becoming an essential tool for advancing ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, and accelerating timelines.

A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs, thanks to the work ...

SDA4Drug is a semi-supervised, few-shot transfer learning method that improves single-cell drug response predictions by transferring knowledge from bulk-level data. It accurately identifies drug ...

Top-down proteomics: Intact proteins are ionized and analyzed directly, allowing for the study of proteoforms and ...

the algorithm generates the blueprints for potential drug molecules that increase or inhibit the activity of the protein. Chemists can then synthesise and test these molecules in the laboratory.